Abstract
2 for T-wave oversensing, and 1 for interference).Complications were encountered in 5 patients (7%) (1 had a pneumothorax post implantation and 4 were device related). Conclusion: In a routine clinical heart failure population, prophylactic ICD implantation provided appropriate therapy for potentially lifethreatening arrhythmias in 25% of the population over a two year follow up, a rate similar to that reported in the clinical trials. With a relatively low complication rate these data indicate translation of clinical trial benefits to the general heart failure population.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
